414 related articles for article (PubMed ID: 17039953)
1. Strategic planning for U.S. premarket approval submissions.
Donawa M
Med Device Technol; 2006 Sep; 17(7):21-3. PubMed ID: 17039953
[TBL] [Abstract][Full Text] [Related]
2. Guidance on submitting quality system information.
Donawa ME
Med Device Technol; 2004 Mar; 15(2):24-7. PubMed ID: 15154336
[TBL] [Abstract][Full Text] [Related]
3. New FDA draft guidance on premarket submissions.
Donawa ME
Med Device Technol; 1999 Oct; 10(8):12-4. PubMed ID: 10724773
[TBL] [Abstract][Full Text] [Related]
4. An important step forward in the global harmonisation of premarket review programmes.
Donawa M
Med Device Technol; 2001 Sep; 12(7):28-30. PubMed ID: 12938557
[TBL] [Abstract][Full Text] [Related]
5. The US medical device bundling policy.
Donawa M
Med Device Technol; 2004 Nov; 15(9):25-7. PubMed ID: 16231784
[TBL] [Abstract][Full Text] [Related]
6. FDA user fee and Modernisation Act.
Donawa M
Med Device Technol; 2002 Dec; 13(10):27-9. PubMed ID: 12575526
[TBL] [Abstract][Full Text] [Related]
7. FDA pilot programme in support of global harmonisation.
Donawa ME
Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
[TBL] [Abstract][Full Text] [Related]
8. Successful recruitment for medical device clinical studies.
Donawa M
Med Device Technol; 2004 Oct; 15(8):25-7. PubMed ID: 16225270
[TBL] [Abstract][Full Text] [Related]
9. Gastroenterology and urology devices; effective date of requirement for premarket approval of the implanted mechanical/hydraulic urinary continence device. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Sep; 65(187):57726-32. PubMed ID: 11503643
[TBL] [Abstract][Full Text] [Related]
10. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
[TBL] [Abstract][Full Text] [Related]
11. Express preemption and premarket approval under the Medical Device Amendments.
Scandaglia GJ; Tully TL
Food Drug Law J; 2004; 59(2):245-64. PubMed ID: 15318395
[No Abstract] [Full Text] [Related]
12. The Center for Devices and Radiological health: an update.
Donawa M
Med Device Technol; 2001 Dec; 12(10):24, 26-7. PubMed ID: 15966141
[TBL] [Abstract][Full Text] [Related]
13. Design controls.
Bartoo G
IEEE Eng Med Biol Mag; 2003; 22(2):112-4. PubMed ID: 12733469
[No Abstract] [Full Text] [Related]
14. Orthopedic devices; effective data of requirement for premarket approval for hip joint metal/polymer or ceramic/polymer semiconstrained resurfacing cemented prosthesis. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Oct; 69(191):59132-4. PubMed ID: 15460583
[TBL] [Abstract][Full Text] [Related]
15. Defending substantial equivalence: an argument for the continuing validity of the 510(k) premarket notification process.
Flaherty JM
Food Drug Law J; 2008; 63(4):901-27. PubMed ID: 19601388
[No Abstract] [Full Text] [Related]
16. Inappropriate attack on device development.
Somberg JC
Am J Ther; 2011; 18(2):91. PubMed ID: 21393999
[No Abstract] [Full Text] [Related]
17. When to conduct a clinical trial.
Boutrand JP
Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
[TBL] [Abstract][Full Text] [Related]
18. US regulation of combination products.
Donawa M
Med Device Technol; 2009 Oct; 20(6):22, 24-5. PubMed ID: 20302139
[TBL] [Abstract][Full Text] [Related]
19. Will new FDA rules hasten device approval?
Hosp Mater Manage; 2003 Jul; 28(7):2, 16. PubMed ID: 12889277
[No Abstract] [Full Text] [Related]
20. Obstetric and gynecology devices; effective date of requirement for premarket approval for glans sheath devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Jun; 67(115):40848-9. PubMed ID: 12068899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
